Abstract-This study examined the association of blood glutathione level, a potential marker of physiological/functional aging, with a number of biomedical/psychological traits in a subgroup (N = 33) of a representative sample of community-based elderly. Higher glutathione levels were associated with fewer number of illnesses (p < 0.05), higher levels of self-rated health (p < O.Ol), lower cholesterol (p < 0.05), lower body mass index, and lower blood pressures. Subjects with diagnoses of arthritis, diabetes, or heart disease (as assessed by physicians) had at least marginally significant lower glutathione levels than those who were disease free. Glutathione, together with age and a measure of suppressed anger, accounted for 39% of the variance of an index of morbidity. Glutathione, by itself, accounted for 24% of the variance. To our knowledge, this is the first evidence of an association of higher glutathione levels with higher levels of physical health in a sample of community-based elderly. Further studies in large samples are needed to investigate glutathione as a potential overall health risk factor for morbidity among the elderly.
INTRODUCTION
The concept of physiological or functional age arose out of the observations that during senescence, elderly people of the same chronological age manifest different levels of decline for numerous physiological parameters. Among several approaches to understanding physiological decline in later life, the search for a metabolite, easily and objectively measured, which would be a marker of functional age, has assumed a central role [l] . Recently, the tripeptide glutathione (GSH) has been suggested as a prime candidate
PI*
Glutathione has several major physiological functions: (1) protecting cells against destructive effects of reactive oxygen intermediates and free radicals; (2) detoxifying external substances such as drugs and environmental pollutants; (3) maintaining red cell membrane stability; and (4) enhancing immunological function through its effects on lymphocytes [2, 3] . These widespread functions suggest that the level of glutathione may have major health effects on the molecular, cellular and organ levels of individuals.
Initial work using animal models of mosquito, mouse and rat, indicated that gluta-thione declined with older age, and paralleled the survival curves [4] [5] [6] ; correction of a glutathione deficiency enhanced longevity in the mosquito [7] . Following these observations, investigators began to examine glutathione in human samples. In a convenience sample of clinically healthy groups, glutathione levels were significantly lower in old (6&79 years) when compared to mature (40-59 years) subjects. However, levels in the very old (80-99 years) were similar to those of the mature group. This curvilinear pattern suggests that this selected sample of very old healthy men and women may represent survivors with extreme longevity [8] .
In another convenience sample of elderly white women, selected on the basis of good health, blood glutathione levels were found to be the highest ever observed [9] . The purpose of the current study is to examine glutathione, for the first time, in a subgroup of a random sample of community-based elderly with wider health range (from poor to excellent). The general hypothesis of the research is that higher glutathione levels are associated with better overall health.
SUBJECTS AND METHODS
Subjects for this pilot study were selected from a random sample (N = 172) of urban, white, independently living elderly over the age of 60, interviewed and medically examined in 1984. The design for selecting the sample for this pilot study (N = 33) aimed to have approximately equal numbers of individuals who rated their health low, medium, and high. We also wanted approximately equal numbers of males and females in two age groups: 60-69 years and >70 years. For those aged 6&69, respondents were first stratified by low, medium, and high self-rated health, and then by gender. Thirteen respondents were randomly selected from this group. All 20 survivors over the age of 70 were then included in this pilot sample. In 1986, the subgroup (N = 33) was reinterviewed, and blood samples were drawn for the glutathione assay. All data for this study were derived from questionnaires and medical examinations administered in 1984 and 1986 at Providence Hospital in Southfield, Michigan.
Health measures
In 1986, using a double blind method, glutathione levels were determined in fasting blood samples. Blood samples were collected in ethylenediamine tetraacetic acid-prepared tubes, immediately placed on crushed ice (OC), and then stored at WC. Samples were shipped in dry ice to the laboratory of Dr C. A. Lang at the University of Louisville for processing. Validation of the sample processing and storage conditions was carried out prior to the beginning of this study and showed that glutathione was stable for more than 20 days in blood samples prepared in this manner [8] . Glutathione was analyzed by the HPLC-DEC method and expressed as ,ug glutathione/lO"' erythrocytes.
This method simultaneously measures reduced and oxidized glutathione, cysteine and other thiols [lo] .
All other health measures were determined in 1984 during an extensive medical examination at Providence Hospital in Southfield, Michigan. Blood pressure was measured by the examining physician on the right arm, with respondent seated, and before other medical tests were performed. Cholesterol was assayed in fasting blood samples. Body mass index was calculated by dividing weight (in kg) by height (in m').
Based on the physician's assessment of presence/absence of a series of illnesses or medical conditions, as well as review of more objective tests (e.g. EKG for heart disease, blood sugar levels for diabetes), a simple summary measure of number of illnesses constituted the mobidity index.
Subjects also responded to a self-rated question, "How would you rate your overall health at the present time?" A dichotomous index of self-perceived health divided the sample into those who responded "good" or "excellent" versus those who rated their health as "very poor, " "poor," or "fair." Idler et al. [l l] have demonstrated that global self-evaluated health status is a significant independent predictor of mortality and have reviewed other studies indicating the same result. Subjects were also asked whether or not they smoked cigarettes or drank alcoholic beverages.
Suppressed anger measure
Suppressed anger has previously been shown to be related to blood pressure [ 12, 131 and to cardiovascular morbidity [14] , and mortality [ 151. A measure of anger suppression modified from prior scales [ 13, 151 was computed as the mean score of three items, namely, "boiling inside . . ., " "brooding . . .," and "feeling hurt . . ., " (but not showing anger), relating to a respondent's characteristic reactions to anger-provoking situations. Subjects who were low on suppressed anger had a mean score of "1" and those who "always" suppressed anger had a mean score of "4".
Statistical analyses
Statistical analyses consisted of determining first order and partial (on age) correlations; analyses of covariance (using age as a covariate); and simple and multiple regression modeling. Because of the pilot character of these analyses (we are assessing possible correlations between glutathione and health indicators), we have used a graduated declaration of significance: ifp < 0.10, we have labeled the finding as marginally significant; and if p < 0.05, we have labeled the finding as statistically significant. If p < 0.01 or p -C 0.001, further differentiation of this level of statistical significance is noted.
RESULTS
We first examined ( Table 1 ) the relationship of a number of morbidity measures to glutathione using simple correlations. Glutathione was found to be positively associated with age (p < 0.01) and marginally positively associated with alcohol status (p -C O.lO), and negatively associated with the morbidity index (p < 0.01) and body mass index (p < 0.05). Two other predictors of morbidity, cholesterol and systolic blood pressure, were negatively associated with glutathione, as expected, but did not reach significance.
The strong positive association between age and glutathione suggested that age might be a potentially confounding influence on the re- lationship between glutathione and the other health attributes; glutathione was thus adjusted for age. Partial correlations, using age-adjusted glutathione increased the significance of the morbidity index (p < 0.001); however, body mass index was no longer significant. We next (Table 2) examined the relationship between age-adjusted glutathione levels and the physician's and subjects' ascertained health measures, using analysis of variance. Glutathione levels were analyzed for several of the individual illnesses. An illness was selected for separate analysis only if at least four respondents had the condition. For every illness, except urinary tract infections, those subjects who possessed the condition had a lower mean glutathione level than those without the condition. Two of the associations were marginally significant: arthritis and diabetes (p < O.lO), and a third, heart disease, was statistically significant (p < 0.05). In addition, respondents who rated their health as "good" or "excellent" had significantly (p < 0.01) higher blood levels of glutathione than did their counterparts in the "very poor"/"poor"/"fair" group. Finally (Table 3) , separate regressions of individual variables on the morbidity index indicated significant associations for 3 of 8 variables (column 1): glutathione, body mass index and alcohol use. The r* for these variables, respectively, were 0.24, 0.11, and 0.09. The multiple regression model, including all the predictors (column 2) accounted for 39% of the variance in the morbidity measure and was significant (p = 0.003). Glutathione was the strongest of partial relationships (/3 = -0.64). The negative coefficient indicates that higher glutathione levels were associated with lower morbidity scores. Although the correlation between age and morbidity in the simple regression was not significant, the stepwise regression indicated that age, adjusted for all other covariates, was a marginally significant independent predictor (p < 0.10) as was the measure of suppressed anger.
DISCUSSION
This study provided evidence that glutathione, together with age, a measure of suppressed anger, and other predictors, accounted for 39% of the variance of an index of morbidity in a sample of independently living elderly adults. However, glutathione when examined by itself accounted by far for the largest portion of 10.34*** tF-value cited is for the main effect in the analysis of variance, where GSH is adjusted for age. $The index equals the sum of "yes" responses (diagnosed and/or treated for) the following conditions: arthritis, glaucoma, asthma, emphysema, TB, high blood pressure, heart disease, circulatory problems, diabetes, ulcers, stomach problems, liver disease, kidney disease, urinary tract infection, cancer/leukemia, anemia, stroke, pneumonia, chronic headaches, and up to two other conditions. Significance level: *p -c 0.10; **p < 0.05; ***p < 0.01. tWhen the stepwise regression model was generated, only the first three predictors (in the order listed) were found to be at least marginally significant. [7] . The evidence from small clinical studies that low levels of glutathione are associated with a number of morbid states is rapidly accumulating. Inasmuch as the glutathione measure is inexpensively and reliably assessed, testing it as a possible clinical indicator of future morbidity or immunodeficiency in diverse samples is worthwhile.
One limitation of the present study is the 2 year hiatus between the physical examination and the glutathione assays. However, in a study with a 1 year follow-up, glutathione levels remained stable for the majority of the study participants [9] . Though the procedures for selecting this subsample were random, one must be cautious about findings from any small-numbered sample. A clearer understanding of the nature and extent of glutathione's role in the aging process awaits further investigation. Both longitudinal studies of large representative samples as well as well-designed experimental studies will be required.
